SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India
14 references·3 citing·30 second hop
Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India (2016)Comparison of Procleix Ultrio Elite and P…Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience (2014)Screening Donated Blood for T…Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario (2014)Decreasing Prevalence of Tran…Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Nucleic acid testing for bloo…Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. (2013)Individual donor nucleic acid…Prevalence of HIV among blood donors in a tertiary care centre of north India (2011)Prevalence of HIV among blood…Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana (2010)Seroprevalence of HIV, HBV, H…Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study (2010)Seroprevalence and Trends in …Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five‐year study (2010)Prevalence of hepatitis B vir…Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Multicenter evaluation of ind…Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201 (2008)Comparison of the analytical …Transfusion-transmitted infections: existing and emerging pathogens. (2006)Transfusion-transmitted infec…The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)The cost‐effectiveness of NAT…Reducing the Risk of Blood Transfusion (2001)Reducing the Risk of Blood Tr…Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Nucleic acid amplification te…Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting (2022)Residual risk estimates of tr…Seven Years Experience in NAT Testing of Blood Donors in a Tertiary Care Centre (2019)Seven Years Experience in NAT…Nucleic acid amplification test (2019)Nucleic acid amplification te…Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. (2001)Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. (2004)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections (2012)Family donors are critical and legitimate in developing countries (2015)The Risk of Transfusion-Transmitted Viral Infections (1996)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)NAT of the United States and Canadian blood supply (2000)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes (2009)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture (2012)Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania (2006)Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study (2016)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety (2015)Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Recommendations for Reporting Cost-effectiveness Analyses (1996)Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States (2004)Estimating the cost of blood: past, present, and future directions (2007)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India (2015)Prevalence and Trends of Major Transfusion Transmissible Infections among Blood Donors in Dire Dawa Blood bank, Eastern Ethiopia: Retrospective Study (1970)Seroprevalence of major blood-borne infections among blood donors in Kano, Nigeria (2012)Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety (2015)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)
this work references cited by second hop

References

  • 2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
  • 2000Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases218 cited
  • 2010Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana174 cited
  • 2010Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study122 cited
  • 2008Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.73 cited
  • 2006Transfusion-transmitted infections: existing and emerging pathogens.69 cited
  • 2010Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five‐year study67 cited
  • 2013Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India56 cited
  • 2008Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 20152 cited
  • 2013Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.48 cited
  • 2014Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience44 cited
  • 2001Reducing the Risk of Blood Transfusion44 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2014
Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario
40 cited
  • 2011Prevalence of HIV among blood donors in a tertiary care centre of north India34 cited
  • Cited by

    • 2019Nucleic acid amplification test14 cited
    • 2022Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting9 cited
    • 2019Seven Years Experience in NAT Testing of Blood Donors in a Tertiary Care Centre7 cited